Dr. Uma Ananth

Dr. Uma Ananth has worked in a variety of roles in the medical field since 2007. Dr. Uma began as a Consultant at Athena Diagnostics Inc., and then moved to Progenika Inc. and Rxi Pharmaceuticals Corp. in 2008. In 2010, they became a Consultant at BioReference Laboratories and GeneDx. In 2012, they joined OpGen as a Consultant, where they also took on the role of Assistant Lab Director. Dr. Uma was a Consultant at Claritas Genomics in 2017, and at QNA dx in 2018. Since 2021, they have been a Consultant and Assistant Lab Director at C2i Genomics. Dr. Uma has also been a Consultant at Metabolon, Inc. (2015) and Windjammer Capital Investors (2014).

Dr. Uma Ananth obtained their PhD in Biochemistry from Maharaja Sayajirao University/Harvard Medical School. Dr. Uma also holds certifications from the State of New York Department of Health as a Lab Director for "Bacteriology -limited to Molecular" (2014) and "Genetic Testing" category (1994). Additionally, they are certified by the Operational Services Divison, Supplier Diversity Office, Commonwealth of Massachusetts as a Minority and Women Business Enterprise (MBE and WBE) (2018), by the Small Business Adminstration as a Women Owned Small Business (2018), and by the Women's Business Enterprise National Council (WBENC) as a Women's Business enterprise (WBE) (2018).